Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of a New Formulation of Ibuprofen 400 mg/10 mL Oral Suspension vs. the Reference Product MOMENTACT 400 mg Film-coated Tablet in Healthy Volunteers

NCT02902302 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT02902302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of a New Formulation of Ibuprofen 400 mg/10 mL Oral Suspension vs. the Reference Product MOMENTACT 400 mg Film-coated Tablet in Healthy Volunteers
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
July 31, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy